Table 4.
Typical routine blood tests in alcoholic liver disease
| Parameter | Pathologic | F0-2(<8 kPa) | F3-4(>8 kPA) | Mean F0-2 | Mean F3-4 |
| GOT (U/L) | > 50 | 56.9% | 78.4% | 89.5 | 135.4 |
| GPT (U/L) | > 50 | 50.6% | 48.6% | 75.0 | 70.6 |
| GGT (U/L) | > 60 | 69.4% | 97.3% | 238.8 | 792.8 |
| AP (U/L) | > 130 | 9.0% | 50.5% | 90.2 | 152.0 |
| Bilirubin total (mg/dL) | > 1.3 | 7.8% | 43.2% | 0.8 | 2.9 |
| INR | > 1.27 | 0.8% | 25.9% | 1.2 | 1.1 |
| Platelets (/nL) | < 150 | 17.5% | 48.6% | 222.5 | 172.0 |
| Ferritin (ng/mL) | > 1000 | 15.6% | 35.4% | 524.7 | 830.7 |
| Ferritin (ng/mL) | > 400 | 39.8% | 60.4% | 524.7 | 830.7 |
| Triglycerides (mg/dL) | > 200 | 29.4% | 25.7% | 187.9 | 206.5 |
| Cholesterine (mg/dL) | > 200 | 65.5% | 52.8% | 225.7 | 202.8 |
| Albumin (g/dL) | < 3.8 | 4.3% | 37.3% | 5.4 | 5.2 |
| Transferrin (g/A) | < 2 | 14.8% | 38.6% | 2.5 | 2.2 |
| Transferrin saturation | > 45% | 32.0% | 45.9% | 42.0 | 48.0 |
| Hepatic steatosis (US) | > 1 | 70.9% | 82.4% | 1.9 | 2.2 |
| Spleen size (cm) | > 11.5 | 7.5% | 35.5% | 9.6 | 11.1 |
| Ascites | > 0 | 0.0% | 20.7% | 0.0 | 0.2 |
| Signs of cirrhosis (US) | > 0 | 1.7% | 43.9% | 0.0 | 0.4 |
| Liver stiffness (final) | > 8 | 0.0% | 100.0% | 4.8 | 32.7 |
| CAP (dB/m) | > 300 | 42.2% | 64.9% | 287.0 | 308.3 |
The table shows percentage and means of pathologic routine blood tests in patients with alcoholic liver disease (ALD) (preliminary data from Salem Medical Center n = 275) solely characterized by non-invasive transient elastography (TE). US: Ultrasonography; CAP: Controlled attenuation parameter (Echosens); GGT: γ-glutamyl transpeptadase; GOT: Glutamic-oxal(o)acetic transaminase; GPT: Glutamate pyruvate transaminase; AFP: α-fetoprotein; AP: Alkaline phosphatase.